NCT06464263View on ClinicalTrials.gov

Dexmedetomidine Versus Midazolam-Fentanyl for Analgesia and Sedation

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 10, 2024

Primary Completion Date

February 1, 2026

Study Completion Date

February 10, 2026

Conditions
Valvular Cardiac Surgeries
Interventions
DRUG

Dexmedetomidine

to investigate the postoperative analgesic-sedative effect of dexmedetomidine versus fentanyl-midazolam to achieve fast-track extubation after adult valvular cardiac surgeries.

Trial Locations (1)

Unknown

RECRUITING

Al-Azhar University hospitals, Cairo

All Listed Sponsors
lead

Egymedicalpedia

INDUSTRY